You just read:

Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Metastatic Breast Cancer

News provided by

Daiichi Sankyo Company, Limited

Aug 29, 2017, 08:05 ET